CFAP36
gene geneOn this page
Also known as MGC15407BARTL1
Summary
CFAP36 (cilia and flagella associated protein 36, HGNC:30540) is a protein-coding gene on chromosome 2p16.1, encoding Cilia- and flagella-associated protein 36 (Q96G28). May act as an effector for ARL3.
Located in ciliary transition zone.
Source: NCBI Gene 112942 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_080667
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30540 |
| Approved symbol | CFAP36 |
| Name | cilia and flagella associated protein 36 |
| Location | 2p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC15407, BARTL1 |
| Ensembl gene | ENSG00000163001 |
| Ensembl biotype | protein_coding |
| Entrez | 112942 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 15 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000339012, ENST00000349456, ENST00000403007, ENST00000406691, ENST00000407816, ENST00000481791, ENST00000490934, ENST00000904948, ENST00000904949, ENST00000904950, ENST00000904951, ENST00000904952, ENST00000924584, ENST00000924585, ENST00000959251, ENST00000959252, ENST00000959253
RefSeq mRNA: 2 — MANE Select: NM_080667
NM_001282761, NM_080667
CCDS: CCDS1854, CCDS62911
Canonical transcript exons
ENST00000349456 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070505 | 55544220 | 55544369 |
| ENSE00001070509 | 55528878 | 55528992 |
| ENSE00001146757 | 55522102 | 55522166 |
| ENSE00001739672 | 55523721 | 55523822 |
| ENSE00001880981 | 55519718 | 55519916 |
| ENSE00001913381 | 55544907 | 55545079 |
| ENSE00003490464 | 55535712 | 55535763 |
| ENSE00003578022 | 55543938 | 55544074 |
| ENSE00003613074 | 55533873 | 55533960 |
| ENSE00003670125 | 55537483 | 55537585 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 98.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 49.6260 / max 1062.1675, expressed in 1821 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20343 | 47.9097 | 1821 |
| 20342 | 1.7163 | 1078 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.67 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.60 | gold quality |
| pituitary gland | UBERON:0000007 | 98.50 | gold quality |
| right testis | UBERON:0004534 | 98.46 | gold quality |
| right uterine tube | UBERON:0001302 | 97.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 97.75 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.74 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.69 | gold quality |
| hypothalamus | UBERON:0001898 | 97.68 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.52 | gold quality |
| testis | UBERON:0000473 | 97.49 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.36 | gold quality |
| putamen | UBERON:0001874 | 97.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.27 | gold quality |
| amygdala | UBERON:0001876 | 97.13 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.99 | gold quality |
| left ovary | UBERON:0002119 | 96.85 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.80 | gold quality |
| pons | UBERON:0000988 | 96.79 | gold quality |
| bronchial epithelial cell | CL:0002328 | 96.75 | gold quality |
| right ovary | UBERON:0002118 | 96.59 | gold quality |
| neocortex | UBERON:0001950 | 96.52 | gold quality |
| thyroid gland | UBERON:0002046 | 96.51 | gold quality |
| frontal cortex | UBERON:0001870 | 96.48 | gold quality |
| bronchus | UBERON:0002185 | 96.42 | gold quality |
| forebrain | UBERON:0001890 | 96.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.38 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.36 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 28.72 |
| E-ANND-3 | yes | 11.81 |
| E-MTAB-9388 | yes | 7.03 |
| E-MTAB-10137 | yes | 4.11 |
| E-CURD-112 | no | 2.84 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The association between Yo and CCDC104 antibodies in paraneoplastic neurological syndromes may indicate functional similarities. (PMID:19680650)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap36 | ENSDARG00000037079 |
| mus_musculus | Cfap36 | ENSMUSG00000020462 |
| rattus_norvegicus | Cfap36 | ENSRNOG00000003901 |
| drosophila_melanogaster | CG14367 | FBGN0038170 |
| caenorhabditis_elegans | WBGENE00022435 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 36 — Q96G28 (reviewed: Q96G28)
Alternative names: Coiled-coil domain-containing protein 104
All UniProt accessions (4): B5MC35, B5MCA1, B5MD16, Q96G28
UniProt curated annotations — full annotation on UniProt →
Function. May act as an effector for ARL3.
Subunit / interactions. Interacts with ARL3.
Subcellular location. Nucleus. Cytoplasm. Cell projection. Cilium. Flagellum.
Tissue specificity. Expressed in several human tissues including brain, testis, heart, lung, pancreas and spleen (at protein level).
Similarity. Belongs to the CFAP36 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96G28-1 | 1 | yes |
| Q96G28-2 | 2 |
RefSeq proteins (2): NP_001269690, NP_542398* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR023379 | BART_dom | Domain |
| IPR038888 | CFAP36 | Family |
| IPR042541 | BART_sf | Homologous_superfamily |
Pfam: PF11527
UniProt features (15 total): region of interest 3, modified residue 3, sequence variant 3, compositionally biased region 3, chain 1, splice variant 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96G28-F1 | 73.92 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 201, 85, 147
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
CCAWYNNGAAR_UNKNOWN, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CILIARY_TRANSITION_ZONE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_CILIARY_BASE, WGTTNNNNNAAA_UNKNOWN, GOCC_CILIUM, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, HAMAI_APOPTOSIS_VIA_TRAIL_UP, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ZNF585B_TARGET_GENES, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): nucleus (GO:0005634), axoneme (GO:0005930), motile cilium (GO:0031514), ciliary transition zone (GO:0035869), ciliary base (GO:0097546), cytoplasm (GO:0005737), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| cilium | 3 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| ciliary transition zone | 1 |
| ciliary transition fiber | 1 |
| intracellular anatomical structure | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP36 | ARL3 | P36405 | 754 |
| CFAP36 | FAM161B | Q96MY7 | 618 |
| CFAP36 | TTC29 | Q8NA56 | 572 |
| CFAP36 | FAM81B | Q96LP2 | 533 |
| CFAP36 | CCDC63 | Q8NA47 | 510 |
| CFAP36 | DNAAF9 | Q5TEA3 | 480 |
| CFAP36 | RIBC2 | Q9H4K1 | 460 |
| CFAP36 | CFAP184 | Q2M329 | 453 |
| CFAP36 | SPICE1 | Q8N0Z3 | 451 |
| CFAP36 | VWA1 | Q6PCB0 | 451 |
| CFAP36 | UNC119B | A6NIH7 | 435 |
| CFAP36 | CDR2 | Q01850 | 429 |
| CFAP36 | FOXB1 | Q99853 | 411 |
| CFAP36 | TEKT3 | Q9BXF9 | 404 |
| CFAP36 | ROPN1L | Q96C74 | 399 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARL3 | UNC119B | psi-mi:“MI:0914”(association) | 0.730 |
| CFAP36 | SNTB2 | psi-mi:“MI:0914”(association) | 0.620 |
| CFAP36 | SNTB2 | psi-mi:“MI:0915”(physical association) | 0.620 |
| Arl3 | CFAP36 | psi-mi:“MI:0407”(direct interaction) | 0.560 |
| CFAP36 | DAZAP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DAZAP2 | CFAP36 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CFAP36 | ARL2 | psi-mi:“MI:0914”(association) | 0.530 |
| CFAP36 | Arl2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ARL3 | psi-mi:“MI:0914”(association) | 0.350 | |
| ARL2 | PTPDC1 | psi-mi:“MI:0914”(association) | 0.350 |
| ARL2 | UNC119B | psi-mi:“MI:0914”(association) | 0.350 |
| NDN | HDLBP | psi-mi:“MI:2364”(proximity) | 0.270 |
| NDN | PABPC1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| RET | NUDT19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| FCHSD2 | CFAP36 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP36 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| CFAP36 | RAC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (32): ARL2 (Affinity Capture-MS), OSBPL9 (Affinity Capture-MS), SNTB2 (Affinity Capture-MS), KCTD10 (Affinity Capture-MS), BDH2 (Affinity Capture-MS), CFAP36 (Reconstituted Complex), CFAP36 (Affinity Capture-MS), CFAP36 (Proximity Label-MS), CFAP36 (Proximity Label-MS), CFAP36 (Proximity Label-MS), CFAP36 (Proximity Label-MS), KCTD10 (Affinity Capture-MS), CFAP36 (Affinity Capture-MS), SNTB2 (Affinity Capture-MS), OSBPL9 (Affinity Capture-MS)
ESM2 similar proteins: A0A1S4D1D3, A0A1W2PR95, A1D9I5, A5D796, A7SD85, B0W6N3, D2K8N5, E1C760, E7EXT2, F7AEX0, O08836, O57476, P51951, P54729, P78318, P92948, Q0CU99, Q16543, Q16891, Q173M7, Q1DM35, Q2PIU8, Q2QY04, Q3ZC62, Q4V8E4, Q4W9M7, Q5AXH3, Q5EAC6, Q5M990, Q5PQS7, Q61081, Q61249, Q63692, Q6PID6, Q7SYB2, Q8C6E0, Q8CAQ8, Q8LDQ4, Q8R3N6, Q93VM9
Diamond homologs: Q1RM35, Q28IH8, Q3ZC62, Q4V8E4, Q7T0S7, Q8C6E0, Q95Y36, Q96G28, Q7SYL1, Q32PC9, Q4R930, Q4V8C5, Q5FW25, Q5R9K8, Q5ZKW5, Q6DDX7, Q9D385, Q9Y2Y0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1702 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:55519915:AGGTA:A | donor_loss | 1.0000 |
| 2:55519916:GGT:G | donor_loss | 1.0000 |
| 2:55519917:GTAAA:G | donor_loss | 1.0000 |
| 2:55519918:T:A | donor_loss | 1.0000 |
| 2:55522094:A:AG | acceptor_gain | 1.0000 |
| 2:55522095:A:G | acceptor_gain | 1.0000 |
| 2:55522097:T:G | acceptor_gain | 1.0000 |
| 2:55522097:TTTAG:T | acceptor_loss | 1.0000 |
| 2:55522098:TTAGT:T | acceptor_loss | 1.0000 |
| 2:55522099:TAGTT:T | acceptor_loss | 1.0000 |
| 2:55522100:A:AG | acceptor_gain | 1.0000 |
| 2:55522100:A:C | acceptor_loss | 1.0000 |
| 2:55522101:G:GG | acceptor_gain | 1.0000 |
| 2:55522101:GT:G | acceptor_gain | 1.0000 |
| 2:55522101:GTT:G | acceptor_gain | 1.0000 |
| 2:55522101:GTTT:G | acceptor_gain | 1.0000 |
| 2:55522101:GTTTT:G | acceptor_gain | 1.0000 |
| 2:55522162:AACTA:A | donor_gain | 1.0000 |
| 2:55522163:ACTA:A | donor_gain | 1.0000 |
| 2:55522164:CTA:C | donor_gain | 1.0000 |
| 2:55522164:CTAGT:C | donor_loss | 1.0000 |
| 2:55522165:TA:T | donor_gain | 1.0000 |
| 2:55522165:TAGTG:T | donor_loss | 1.0000 |
| 2:55522166:AGT:A | donor_loss | 1.0000 |
| 2:55522167:GTGA:G | donor_gain | 1.0000 |
| 2:55522169:GAGTA:G | donor_loss | 1.0000 |
| 2:55522171:G:GG | donor_gain | 1.0000 |
| 2:55523715:TTTTA:T | acceptor_loss | 1.0000 |
| 2:55523716:TTTA:T | acceptor_loss | 1.0000 |
| 2:55523718:TA:T | acceptor_loss | 1.0000 |
AlphaMissense
2278 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:55519874:T:A | W25R | 0.999 |
| 2:55519874:T:C | W25R | 0.999 |
| 2:55522104:T:C | F40L | 0.999 |
| 2:55522106:T:A | F40L | 0.999 |
| 2:55522106:T:G | F40L | 0.999 |
| 2:55528920:T:C | F109L | 0.999 |
| 2:55528922:T:A | F109L | 0.999 |
| 2:55528922:T:G | F109L | 0.999 |
| 2:55528960:T:C | L122P | 0.999 |
| 2:55528965:G:C | A124P | 0.999 |
| 2:55544983:T:A | L335H | 0.999 |
| 2:55544983:T:C | L335P | 0.999 |
| 2:55522105:T:C | F40S | 0.998 |
| 2:55522146:C:G | H54D | 0.998 |
| 2:55522155:T:G | Y57D | 0.998 |
| 2:55523722:T:A | V61D | 0.998 |
| 2:55523776:T:C | F79S | 0.998 |
| 2:55528911:T:C | F106L | 0.998 |
| 2:55528913:T:A | F106L | 0.998 |
| 2:55528913:T:G | F106L | 0.998 |
| 2:55528921:T:C | F109S | 0.998 |
| 2:55519832:T:A | W11R | 0.997 |
| 2:55519832:T:C | W11R | 0.997 |
| 2:55519860:T:C | L20P | 0.997 |
| 2:55519895:T:C | F32L | 0.997 |
| 2:55519897:T:A | F32L | 0.997 |
| 2:55519897:T:G | F32L | 0.997 |
| 2:55522105:T:G | F40C | 0.997 |
| 2:55522129:T:C | L48S | 0.997 |
| 2:55522155:T:C | Y57H | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000056935 (2:55536470 G>T), RS1000079986 (2:55521589 GTATA>G,GTA,GTATATA), RS1000121024 (2:55539042 T>C), RS1000149719 (2:55545236 T>C), RS1000174078 (2:55524884 G>A), RS1000347602 (2:55533316 G>A), RS1000430924 (2:55528234 T>C,G), RS1000432731 (2:55519509 C>T), RS1000500728 (2:55540858 C>T), RS1000587944 (2:55536501 A>G), RS1000676840 (2:55533098 C>T), RS1000682828 (2:55536771 G>A), RS1000737642 (2:55530170 A>C), RS1000742234 (2:55519235 G>C), RS1000906428 (2:55542619 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_365 | Refractive error | 3.000000e-34 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression | 3 |
| Cyclosporine | increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| K 7174 | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.